News UChicago Spinout Pyxis Secures $152 Million Series B, Signs Licensing Agreement with Pfizer The University of Chicago spinout Pyxis Oncology has signed a worldwide licensing agreement with Pfizer after raising $152 million to further advance its portfolio of potent biologics. Pyxis in 2019...
News UChicago Invests $300,000 in Groundbreaking New Immunotherapy Startup Founded by University Professor as Part of $22 Million Series A Pyxis Oncology is the sixth recipient of a venture investment from the UChicago Startup Investment Program.
News UChicago’s Polsky Center Celebrates Three Startup Exits in Two Months Series of Startup Exits Solidify the Polsky Center as a ‘Venture Creation’ Engine Three startups supported by the University of Chicago’s Polsky Center for Entrepreneurship and Innovation – NowPow, Pyxis,...
News Looking to Advance New Drugs to the Clinic, UChicago Spinout Pyxis Files for $100M IPO The University of Chicago spinout Pyxis Oncology has filed for an initial public offering (IPO) after earlier this year signing a worldwide licensing agreement with Pfizer and raising $152 million in...
Technology Microbiome-Based Therapeutic For Enhancing Anti-Tumor Immunity In Cancer Treatment Innovative therapeutic strategy leveraging commensal microbiota, specifically by oral administration of Bifidobacterium, to enhance anti-tumor immunity, potentially improving cancer treatment when combined with checkpoint inhibitors Unmet Need: Only 20-40%…
News Evelo Bioscience, a Biotech Company Based on UChicago-licensed Technology, Debuts on Nasdaq Evelo is dedicated to improving the lives of patients globally through the development of a new modality of medicines called monoclonal microbials
News UChicago Professors and Grad Students Among 2021’s Highly Cited Researchers More than 30 professors and graduate students at the University of Chicago were among Clarivate’s annual list of Highly Cited Researchers. The list, which included University of Chicago President, Paul...
News DeepTechU Day 3: Advice for Deep Tech Entrepreneurs, the Future of Immunotherapy, and Opportunities in Quantum Day 3 of DeepTechU featured advice for entrepreneurs developing deep tech innovations, a look at the current and future immunotherapy market, and a Fireside Chat about growing the quantum ecosystem....
Technology Synergistic Combination of Immunologic Inhibitors for the Treatment of Cancer Current immunotherapy approaches often focus on targeting a single immune checkpoint or suppressive pathway, which can be insufficient given the redundancy and adaptability of tumor-mediated immune evasion. Tumors can compensate…
News Buoyed by Insiders, Flagship’s Evelo Hits Midpoint of IPO Range Evelo Biosciences, a biotech company based on technology licensed through the Polsky Center from UChicago Medicine’s Thomas Gajewski, debuted on Nasdaq. Read the full article >>
News Halo Awards to Honor ‘Heroes Of Medicine’ and 40 Under 40 Chicago Scientists, Featuring Many Polsky Partners The second Annual Halo Awards will take place Saturday, October 12, at 6:00 p.m. at the Museum of Science and Industry, celebrating the city’s “Heroes of Medicine” and the 40...
News From Idea to Impact // February 2019 The George Shultz Innovation Fund awards $600K, Tao Pan develops tRNA sequencing technique, Thomas Gajewski talks immunotherapy treatments, and Bozhi Tian to create new kind of pacemaker.
